Back to Search
Start Over
Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice
- Publication Year :
- 2023
-
Abstract
- HIV infection has been associated with lower rates of sustained viral response (SVR) with direct-acting antivirals (DAAs). There are few data on glecaprevir/pibrentasvir (G/P) in HIV/HCV coinfection outside clinical trials.
Details
- Database :
- OAIster
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1435812074
- Document Type :
- Electronic Resource